<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>LABOKLIN aktuell 2019 &#8211; LABOKLIN Europe</title>
	<atom:link href="https://laboklin.com/en/category/laboklin-aktuell-2019/feed/" rel="self" type="application/rss+xml" />
	<link>https://laboklin.com/en/</link>
	<description>Laboratory for clinical diagnostics</description>
	<lastBuildDate>Wed, 24 Jul 2024 10:36:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.8.5</generator>
	<item>
		<title>Laboratory diagnostics in guinea pigs</title>
		<link>https://laboklin.com/en/laboratory-diagnostics-in-guinea-pigs/</link>
		
		<dc:creator><![CDATA[LABOKLIN &#124; Bad Kissingen]]></dc:creator>
		<pubDate>Tue, 03 Dec 2019 09:02:35 +0000</pubDate>
				<category><![CDATA[LABOKLIN aktuell 2019]]></category>
		<guid isPermaLink="false">https://staging-wp-int.laboklin.com/?p=1460673</guid>

					<description><![CDATA[For sick guinea pigs, laboratory diagnostics remain an important part of the diagnostic workup.]]></description>
										<content:encoded><![CDATA[<div class="wpb-content-wrapper"><div class="vc_row wpb_row vc_row-fluid dt-default" style="margin-top: 0px;margin-bottom: 0px"><div class="wpb_column vc_column_container vc_col-sm-8"><div class="vc_column-inner"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			<p>For sick guinea pigs, laboratory diagnostics remain an important part of the diagnostic workup. Due to the non-specific clinical signs, which for owners are only visible at a late stage, guinea pigs are often presented with rather advanced disease. At this point, laboratory diagnostics is usually crucial. It is also commended in cases of poor body condition, inappetence or as part of a preoperative screening in addition to further imaging techniques.</p>
<h2>Pre-analytics</h2>
<p>As guinea pigs and other small mammals are flight animals and therefore more susceptible to stress than dogs and cats, it is important to have all necessary materials ready before blood sampling, thereby reducing the manipulation time to a minimum.</p>
<p>Due to the small body size and total blood volume (69-75 ml/kg), small blood tubes are recommended. Lithium heparin tubes are particularly suitable for guinea pigs, as it is possible to determine T4 and fT4, besides analysing clinical-chemical parameters and a complete blood count. Lithium heparin blood (1 ml) is therefore a good alternative to EDTA blood and serum if, one expects a small amounts of blood upon sampling.<br />
Furthermore, it is recommended to make blood smears directly in the practice in order for the lab to be able to evaluate the differential blood count in case of transport-related cell degenerations.</p>
<p><u>Puncture sites</u></p>
<p>Blood can be collected at different puncture sites using a G20 – G21 needle (with or without cone).<br />
The lateral saphenous vein is most suitable for this. It is located caudally on the lower leg and is clearly visible and palpable (Fig. 1a). A puncture (Fig. 1b) is performed at half height between the femoral canal and the tarsal joint at an angle of 30° to the leg axis.</p>
<p>It is also possible to puncture the vena Cephalica antebrachii, located laterally on the foreleg (Fig. 2). Here, it is recommended to position the leg parallel to the edge of the table.</p>
<h2>Haematology</h2>
<p>Compared to other species, guinea pigs have fewer, but larger erythrocytes (6.6- 7.9 µm). Haematocrit (0.39-0.55 l/l) is similar to that of dogs; young animal anaemia can also occur. Determination of reticulocytes for the classification of anaemia is also possible in guinea pigs (Kaufhold et al., 2017).</p>
<p>In contrast to dogs and cats, guinea pigs have a lymphocytic blood count. Physiologically, more lymphocytes than neutrophil granulocytes circulate in the peripheral blood. By acute bacterial infections or inflammation, a so-called “pseudo left shift” occurs – a shift from lymphocytic to granulocytic blood count. In this case, a marked leukocytosis as well as the presence of band neutrophils are, compared to other species, rarely seen. By the so-called “stress leukogram” are lymphocytes and granulocytes almost equally distributed.</p>
<p>Neutrophil granulocytes in guinea pigs are also referred to as “pseudo-eosinophils” (Fig. 4) due to their acidophilic staining. These can easily be confused with eosinophil granulocytes, but are smaller in comparison, as their nucleus is less segmented and contains smaller granules.</p>
<p>Eosinophilia occurs, in contrast to rabbits, not only by tissue injury and infections of tissue containing mastocytes (skin, lungs, gastrointestinal tract, uterus), but also by parasitosis.<br />
Guinea pigs can also develop leukaemic lymphomas with severe leukocytosis, which, compared with other species, can easily be diagnosed by a blood examination.</p>
<p>Foa-Kurloff cells (Fig. 6) represent one last haematological feature of this species. Foa-Kurloff cells are mononuclear leukocytes (often lymphocytes, rarely monocytes) with inclusion bodies (Kurloff bodies), which should not be mistaken for intracellular pathogens, due to their appearance. They can make up 3-4% of the leukocytes.</p>
<p>A particularly high number of these inclusion bodies is described during pregnancy and correlates with the oestrogen level. They are most likely equivalent to the killer cells in other mammals and provide a barrier between foetus and mother.</p>
<h2>Clinical chemistry</h2>
<p>Most laboratories offer so-called Rodent Profiles, which provide a good overview of the individual metabolic status. Often liver, kidney and muscle parameters included, as well as fructosamine, total protein and electrolytes.</p>
<p>Most laboratories offer so-called Rodent Profiles, which provide a good overview of the individual metabolic status. Often liver, kidney and muscle parameters included, as well as fructosamine, total protein and electrolytes.</p>
<p>In order to assess hepatic metabolism, attention should be paid to enzyme changes in GLDH, ALT and AST. In guinea pigs, GLDH is a sensitive enzyme and increases rapidly by acute hepatopathies, although it can be found in kidney cells too. As ALT and AST occur in low concentrations, not only in the liver, but also in other organs, they are not specific for hepatocellular damage. Increased enzyme concentrations, combined with other elevated liver parameters, indicate chronic hepatic disease. Increased AST activity should always be assessed in conjunction with CK, as AST is not only found in the liver, kidney and pancreas, but also in myocardial and skeletal muscle cells.<br />
Although the lipid metabolism in guinea pigs is less active than that of rabbits, they tend to develop hepatic lipidosis. Both AP and γ-GT are slow to react and only increase by chronic conditions. Evaluation of urea and creatinine does not differ from other animal species.</p>
<p>As especially coprophagic herbivores never fast (and should not be fasted before blood sampling), they generally have high glucose levels of 5.0-16.0 mmol/l. However, the physiological fructosamine level is comparatively low at &lt; 271 µmol/l. Glucose is a significant prognostic factor by ileus or stasis. The higher and longer a hyperglycaemia persist, the worse the prognosis for the affected animal. An additional drop in sodium (Na) (&lt; 129 mmol/l) increases the mortality rate by a factor of 2.3 (Bonhevi et al., 2014).</p>
<h2>Endocrinology</h2>
<p>In contrast to dogs and cats, hormonal diseases in guinea pigs are described in low number. Cases of hyperthyroidism, Morbus Cushing, diabetes mellitus and insulinoma are reported.</p>
<p><u>Hyperthyroidism</u></p>
<p>Hyperthyroid animals are often presented at an older age, with progressive weight loss, despite a constant or increased appetite, proliferation of the ventral neck as well as behavioural changes. As the disease progresses, PU/PD, alopecia, inappetence, chronic diarrhoea and cardiac problems can occur.</p>
<p>For diagnosis, T4 should be determined (at least 250 µl of serum or heparin plasma). To exclude differential diagnoses, blood, urine and faecal examinations are recommended as well as a cytological examination of the mass.</p>
<p><u>Morbus Cushing / Hyperadrenocorticism</u></p>
<p>Patients with suspected Morbus Cushing are often presented with bilateral alopecia beginning on the flanks and the ventral abdomen, apathy, PU/PD, polyphagia and bilateral exophthalmos. Thinner skin, weight loss and muscular atrophy may also be seen later in the course of the disease.</p>
<p>Diagnostically, a dexamethasone suppression test, as well as an ACTH stimulation test (from blood or saliva) can be used. Due to the pulsatile secretion of ACTH at a high frequency, guinea pigs generally have high baseline cortisol levels in their blood. Any stress, such as blood sampling, additionally increases the cortisol level.<br />
A low-stress alternative is to measure the cortisol level from saliva. The ACTH stimulation test procedure is the same using saliva as from blood. A baseline sample is taken, 20 I.E. ACTH is injected i.m., and the stimulation sample is taken four hours post injection. It is mandatory to use Salivettes for obtaining saliva samples (Fig. 7, Salivette®, Sarstedt).</p>

		</div>
	</div>
</div></div></div><div class="wpb_column vc_column_container vc_col-sm-4"><div class="vc_column-inner"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			
<a href='https://laboklin.com/en/ms_tma_v_saphena_1/'><img fetchpriority="high" decoding="async" width="265" height="405" src="https://laboklin.com/wp-content/uploads/2022/10/MS_TMA_V_saphena_1.jpg" class="attachment-large size-large" alt="Laboklin: Vena Saphena lateralis caudally on the lower limb" srcset="https://laboklin.com/wp-content/uploads/2022/10/MS_TMA_V_saphena_1.jpg 265w, https://laboklin.com/wp-content/uploads/2022/10/MS_TMA_V_saphena_1-196x300.jpg 196w" sizes="(max-width: 265px) 100vw, 265px" /></a>
<a href='https://laboklin.com/en/ms_tma_v_saphena_2/'><img decoding="async" width="267" height="408" src="https://laboklin.com/wp-content/uploads/2022/10/MS_TMA_V_saphena_2.jpg" class="attachment-large size-large" alt="Laboklin: Puncture of vena Saphena lateralis with a G20 needle" srcset="https://laboklin.com/wp-content/uploads/2022/10/MS_TMA_V_saphena_2.jpg 267w, https://laboklin.com/wp-content/uploads/2022/10/MS_TMA_V_saphena_2-196x300.jpg 196w" sizes="(max-width: 267px) 100vw, 267px" /></a>
<a href='https://laboklin.com/en/ms_tma_v_cephalica/'><img decoding="async" width="279" height="245" src="https://laboklin.com/wp-content/uploads/2022/10/MS_TMA_V_cephalica.jpg" class="attachment-large size-large" alt="Laboklin: Vena Cephalica antebrachii laterally on the foreleg" /></a>
<a href='https://laboklin.com/en/fig-3-4/'><img loading="lazy" decoding="async" width="1010" height="1015" src="https://laboklin.com/wp-content/uploads/2022/10/Fig.3.jpg" class="attachment-large size-large" alt="Laboklin: Distribution of leukocytes" srcset="https://laboklin.com/wp-content/uploads/2022/10/Fig.3.jpg 1010w, https://laboklin.com/wp-content/uploads/2022/10/Fig.3-300x300.jpg 300w, https://laboklin.com/wp-content/uploads/2022/10/Fig.3-150x150.jpg 150w, https://laboklin.com/wp-content/uploads/2022/10/Fig.3-768x772.jpg 768w" sizes="auto, (max-width: 1010px) 100vw, 1010px" /></a>
<a href='https://laboklin.com/en/4-21-2/'><img loading="lazy" decoding="async" width="534" height="455" src="https://laboklin.com/wp-content/uploads/2023/03/4-10.jpg" class="attachment-large size-large" alt="" srcset="https://laboklin.com/wp-content/uploads/2023/03/4-10.jpg 534w, https://laboklin.com/wp-content/uploads/2023/03/4-10-300x256.jpg 300w" sizes="auto, (max-width: 534px) 100vw, 534px" /></a>
<a href='https://laboklin.com/en/5-20-2/'><img loading="lazy" decoding="async" width="532" height="460" src="https://laboklin.com/wp-content/uploads/2023/03/5-9.jpg" class="attachment-large size-large" alt="" srcset="https://laboklin.com/wp-content/uploads/2023/03/5-9.jpg 532w, https://laboklin.com/wp-content/uploads/2023/03/5-9-300x259.jpg 300w" sizes="auto, (max-width: 532px) 100vw, 532px" /></a>
<a href='https://laboklin.com/en/6-8-2/'><img loading="lazy" decoding="async" width="725" height="525" src="https://laboklin.com/wp-content/uploads/2023/03/6-5.jpg" class="attachment-large size-large" alt="" srcset="https://laboklin.com/wp-content/uploads/2023/03/6-5.jpg 725w, https://laboklin.com/wp-content/uploads/2023/03/6-5-300x217.jpg 300w" sizes="auto, (max-width: 725px) 100vw, 725px" /></a>
<a href='https://laboklin.com/en/7-9-2/'><img loading="lazy" decoding="async" width="433" height="237" src="https://laboklin.com/wp-content/uploads/2023/03/7-5.jpg" class="attachment-large size-large" alt="" srcset="https://laboklin.com/wp-content/uploads/2023/03/7-5.jpg 433w, https://laboklin.com/wp-content/uploads/2023/03/7-5-300x164.jpg 300w" sizes="auto, (max-width: 433px) 100vw, 433px" /></a>
<a href='https://laboklin.com/en/8-4-2/'><img loading="lazy" decoding="async" width="287" height="213" src="https://laboklin.com/wp-content/uploads/2023/03/8-2.jpg" class="attachment-large size-large" alt="" /></a>


		</div>
	</div>
</div></div></div></div><div class="vc_row wpb_row vc_row-fluid dt-default" style="margin-top: 0px;margin-bottom: 0px"><div class="wpb_column vc_column_container vc_col-sm-12"><div class="vc_column-inner vc_custom_1711629055928"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			<p>The plastic fibre roll inside the Salivette® is placed between the molars and buccal mucosa for five minutes. To prevent it from sliding, the plastic fibre roll can be fixated (Fig. 8). After successful sampling, the plastic fibre roll is placed back into the Salivette® and shipped to the lab.</p>
<p>A Dexamethasone suppression test (LDDS with 0.01 mg/kg or HDDS with 0.1 mg/kg of dexamethasone) is possible, although, no valid reference values are available so far in the literature. Similar to dogs, the suppression of the cortisol level is decisive in this case.<br />
However, in guinea pigs Morbus Cushing is still a diagnosis of exclusion and should be verified by further examinations, such as sonography of the adrenal glands.</p>
<p><u>Diabetes mellitus</u></p>
<p>Affected animals mainly suffer from obesity and PU/PD. Bilateral cataracts are described. Both, the hereditary type I, as well as the acquired type II occur.</p>
<p>Laboratory diagnostics show a marked hyperglycaemia, increased fructosamine levels and glucosuria. To exclude differential diagnoses, a Rodent Profile including complete blood count, T4 and an ACTH stimulation test, as well as a urinalysis should be performed.</p>
<p><u>Insulinoma</u></p>
<p>So far, only two cases are described in the literature. Weakness, paralysis as well as convulsions and seizures were described. Low glucose and fructosamine levels were found on the clinical-chemistry analysis. Insulin measurement is not recommend-ed, due to intermittent secretion and lack of reference values.</p>
<h2>Conclusion</h2>
<p>Blood testing in guinea pigs has established itself over the past 50 years, due to the steadily growing number of domestic small mammals. However, further research is needed.</p>

		</div>
	</div>
</div></div></div></div><div class="vc_row wpb_row vc_row-fluid vc_custom_1712131403386 vc_column-gap-10"><div class="wpb_column vc_column_container vc_col-sm-6"><div class="vc_column-inner"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element  vc_custom_1712133759848" >
		<div class="wpb_wrapper">
			<h5><strong>Literature</strong></h5>
<h6><span style="color: #808080;"><strong>Bonvehi et al. (2014): Prevalence and types of hyponatraemia, its relationship with hyperglycaemia and mortality in ill pet rabbits. Vet Rec., 174(22):554.</strong></span></h6>
<h6><span style="color: #808080;"><strong>Kaufhold et al. (2017): Retikulozytenzahlen beim Meerschweinchen – Referenzwerte und Vergleich der manuellen und automatischen Zählung mit dem Advia 2120i. InnLab, Göttingen, 2017.</strong></span></h6>

		</div>
	</div>
</div></div></div><div class="wpb_column vc_column_container vc_col-sm-6"><div class="vc_column-inner"><div class="wpb_wrapper"><div class="vc_row wpb_row vc_inner vc_row-fluid vc_column-gap-10 vc_row-o-equal-height vc_row-o-content-middle vc_row-flex"><div class="wpb_column vc_column_container vc_col-sm-3 vc_col-has-fill"><div class="vc_column-inner vc_custom_1721816878334"><div class="wpb_wrapper"><div class="vc_icon_element vc_icon_element-outer vc_custom_1721816886035 vc_do_icon vc_icon_element-align-center"><div class="vc_icon_element-inner vc_icon_element-color-custom vc_icon_element-size-xl vc_icon_element-style- vc_icon_element-background-color-grey" ><span class="vc_icon_element-icon fas fa-file-pdf" style="color:#e51e1e !important"></span><a class="vc_icon_element-link" href="https://laboklin.com/wp-content/uploads/2022/10/Aktuell-Guinea-pig-diagnostics-INT_Timmol_FAL.pdf"  title="Laboratoy diagnostics in guinea pigs" target="_blank"></a></div></div></div></div></div><div class="wpb_column vc_column_container vc_col-sm-9 vc_col-has-fill"><div class="vc_column-inner vc_custom_1721816900397"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element  vc_custom_1721816910014" >
		<div class="wpb_wrapper">
			<p><strong><a href="https://laboklin.com/wp-content/uploads/2022/10/Aktuell-Guinea-pig-diagnostics-INT_Timmol_FAL.pdf" target="_blank" rel="noopener">Laboratory diagnostics in guinea pigs</a></strong></p>

		</div>
	</div>
</div></div></div></div></div></div></div></div>
</div>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>BRAF mutation in canine transitional cell and prostate carcinoma</title>
		<link>https://laboklin.com/en/braf-mutation-in-canine-transitional-cell-and-prostate-carcinoma/</link>
		
		<dc:creator><![CDATA[Laboklin &#124; Bad Kissingen]]></dc:creator>
		<pubDate>Tue, 01 Oct 2019 11:00:08 +0000</pubDate>
				<category><![CDATA[LABOKLIN aktuell 2019]]></category>
		<guid isPermaLink="false">https://staging.laboklin.com/int/en/?p=1316735</guid>

					<description><![CDATA[In dogs, both transitional cell carcinoma (TCC, Fig. 1) and prostate carcinoma (PCa) are highly malignant neoplasms (GRIFFIN et al. 2018).]]></description>
										<content:encoded><![CDATA[<div class="wpb-content-wrapper"><div class="vc_row wpb_row vc_row-fluid dt-default" style="margin-top: 0px;margin-bottom: 0px"><div class="wpb_column vc_column_container vc_col-sm-8"><div class="vc_column-inner"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			<h2>Transitional cell and prostate carcinoma</h2>
<p>In dogs, both transitional cell carcinoma (TCC, Fig. 1) and prostate carcinoma (PCa) are highly malignant neoplasms (GRIFFIN et al. 2018). Both types of tumour are often <strong>diagnosed</strong> rather <strong>late</strong> (BRYAN et al. 2007; PANTKE 2018). Consequently, prognosis for affected dogs is bad (CORNELL et al. 2000; HENRY 2003). The <strong>median survival time</strong> is one year for dogs with TCC and 30 days for dogs with PCa (HENRY 2003; CORNELL et al. 2000). The median age of affected dogs is 11 (TCC) and 10 years (PCa) (CORNELL et al. 2000; KNAPP et al. 2000). For a long time, there was no reliable screening test for the presence of TCC, particularly for breeds with increased genetic risk (certain terrier breeds).</p>
<h2>BRAF mutation</h2>
<p>The presence of BRAF variant V595E, known from human medicine, was studied for the first time on a large number of tumours in dogs by MOCHIZUKI et al. in 2015. In contrast to people, where the mutation occurs mainly in malignant melanoma, ovarian tumours and colorectal carcinoma, in dogs, MOCHIZUKI et al. (2015) most often found the mutation in <strong>transitional cell</strong> and <strong>prostate carcinomas</strong>. It is a somatic <strong>mutation</strong> in the <strong>BRAF gene</strong> which only occurs in the <strong>tumour cells</strong>. It is assumed that this mutation leads to <strong>tumour development</strong> through permanent activation of the MAP kinase pathway.</p>
<h2>BRAF mutation in canine transitional cell carcinoma</h2>
<p>In 2018, we succeeded in establishing the method for detecting BRAF mutation in TCC in our laboratory (AUPPERLE-LELLBACH et al. 2018). <strong>Specificity</strong> was <strong>100%</strong> as the BRAF mutation could not be detected in any of the dogs with cystitis, urinary bladder polyp or in those without any clinical and pathological signs. <strong>Sensitivity</strong> of BRAF mutation detection in TCC was <strong>71%.</strong></p>
<p>Possible sample materials:</p>
<ul>
<li>tissue (e.g. biopsies)</li>
<li>cytological smears (e.g. FNA)</li>
<li>urine rich in cells (early morning urine)</li>
</ul>
<p>In the literature, the test has so far only been described for tissue samples and urine. In our studies, we have also succeeded in <strong>establishing</strong> it for <strong>cytological smears</strong> of fine needle aspirates and urinary sediments.</p>
<p>Thus, <strong>invasive sampling</strong> can be <strong>avoided</strong> by testing spontaneous urine, or there is <strong>no</strong> <strong>repeated invasive sampling</strong> <strong>necessary</strong> in cases of <strong>questionable histopathological</strong> and <strong>cytological diagnoses</strong> (poor sample quality, overlapping images of inflammation and neoplasia).</p>
<p>A <strong>breed predisposition</strong> has been described for canine <strong>TCC</strong> in Scottish, Fox and West Highland White <strong>Terrier</strong> (FULKERSON und KNAPP 2015). Another study also showed a predisposition for BRAF mutation in different long- and short-legged terriers (AUPPERLE-LELLBACH et al. 2019). It can thus be concluded that detection of <strong>BRAF mutation</strong> in these terrier breeds is not only <strong>highly specific</strong> for the presence of TCC, but also <strong>very sensitive</strong> (Fig. 2) and can be used as a <strong>screening test</strong> for the presence of TCC.</p>

		</div>
	</div>
</div></div></div><div class="wpb_column vc_column_container vc_col-sm-4"><div class="vc_column-inner"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			
<a href='https://laboklin.com/en/braf-mutation-in-canine-transitional-cell-and-prostate-carcinoma/la_oktober_2019_eng_seite_1_bild_0002/'><img loading="lazy" decoding="async" width="1024" height="692" src="https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_1_Bild_0002-1024x692.jpg" class="attachment-large size-large" alt="Laboklin: Sonographic image of the urinary bladder. A papillary mass clearly protrudes into the lumen of the bladder." srcset="https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_1_Bild_0002-1024x692.jpg 1024w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_1_Bild_0002-300x203.jpg 300w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_1_Bild_0002-768x519.jpg 768w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_1_Bild_0002.jpg 1328w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></a>
<a href='https://laboklin.com/en/braf-mutation-in-canine-transitional-cell-and-prostate-carcinoma/la_oktober_2019_eng_seite_2_bild_0001/'><img loading="lazy" decoding="async" width="490" height="332" src="https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0001.jpg" class="attachment-large size-large" alt="Laboklin: Correlation between BRAF mutation and dog breed. Terriers were significantly more likely to show BRAF mutation in transitional cell carcinoma than other breeds." srcset="https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0001.jpg 490w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0001-300x203.jpg 300w" sizes="auto, (max-width: 490px) 100vw, 490px" /></a>
<a href='https://laboklin.com/en/braf-mutation-in-canine-transitional-cell-and-prostate-carcinoma/la_oktober_2019_eng_seite_2_bild_0002/'><img loading="lazy" decoding="async" width="1024" height="768" src="https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0002-1024x768.jpg" class="attachment-large size-large" alt="Laboklin: Cytological picture of prostate carcinoma with prostatitis: numerous partly degenerated neutrophil granulocytes and clusters of pleomorphic prostate epithelial cells with large, differently shaped cell nuclei (Haema Quick Stain, bar = 25 µm)" srcset="https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0002-1024x768.jpg 1024w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0002-300x225.jpg 300w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0002-768x576.jpg 768w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0002-1536x1152.jpg 1536w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0002-2048x1536.jpg 2048w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></a>
<a href='https://laboklin.com/en/braf-mutation-in-canine-transitional-cell-and-prostate-carcinoma/la_oktober_2019_eng_seite_2_bild_0003/'><img loading="lazy" decoding="async" width="1024" height="768" src="https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0003-1024x768.jpg" class="attachment-large size-large" alt="Laboklin: Histological picture of a highly aggressive, tubulopapillary prostate carcinoma with infiltrative growth (Gleason Pattern 3, score sum 8, bar = 100 µm)" srcset="https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0003-1024x768.jpg 1024w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0003-300x225.jpg 300w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0003-768x576.jpg 768w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0003-1536x1152.jpg 1536w, https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_Seite_2_Bild_0003-2048x1536.jpg 2048w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></a>


		</div>
	</div>
</div></div></div></div><div class="vc_row wpb_row vc_row-fluid dt-default" style="margin-top: 0px;margin-bottom: 0px"><div class="wpb_column vc_column_container vc_col-sm-12"><div class="vc_column-inner vc_custom_1705309430099"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			<p>No gender or age predisposition for BRAF mutation could be shown in this study. There was also <strong>no correlation</strong> between the detection of <strong>BRAF mutation</strong> and the <strong>invasivity</strong> or <strong>aggressiveness</strong> of TCC in dogs (GRASSINGER et al. 2019).</p>
<p>In a small study (n=10), <strong>carcinomas of the kidney</strong> tubules did not show BRAF mutation. However, two of six carcinomas of the transitional epithelium of the renal pelvis were positive (AUPPERLE-LELLBACH et al. 2019).</p>
<h2>BRAF mutation in canine prostate carcinoma (PCa)</h2>
<p>For canine PCa (Fig. 3) as well, detection of BRAF mutation from different materials could be established (GRASSINGER et al. 2019).</p>
<p>Possible sample materials:</p>
<ul>
<li>tissue (e.g. biopsies)</li>
<li>cytological smears (e.g. FNA)</li>
</ul>
<p>Again, <strong>specificity </strong>was <strong>100%</strong> as the mutation could neither be detected in samples with benign prostatic hyperplasia, squamous epithelial metaplasia, atrophy of the prostate nor in normal prostate tissue.</p>
<p><strong>Sensitivity </strong><strong>of</strong> BRAF mutation <strong>detection</strong> in canine PCa was <strong>61%</strong>.</p>
<p>Based on a histological score, <strong>prostate carcinomas caused by BRAF mutation </strong>(Fig. 4) were much more <strong>aggressive</strong> than those not caused by this mutation (GRASSINGER et al. 2019).</p>
<h2>Conclusion</h2>
<p>BRAF mutation testing is a <strong>highly specific</strong> method (<strong>100%</strong>) for the detection of canine transitional cell and prostate carcinoma.</p>
<p><strong>Sensitivity</strong>, however, varies depending on the site (kidney, urinary bladder, urethra, prostate gland) and possibly the breed:</p>
<p><em>Transitional cell carcinoma:<br />
</em>86% long- and short-legged terrier<br />
44% other breeds</p>
<p><em>Prostate carcinoma: </em>60%</p>
<p>Testing for BRAF is <strong>indicated</strong> in cases in which</p>
<ul>
<li>invasive sampling should be avoided,</li>
<li>the cytological/histological result is not conclusive.</li>
</ul>
<p>Only a <strong>positive result</strong> confirms a carcinoma.</p>
<p>If no <strong>BRAF mutation</strong> is detected in the sample, it may be because of the following reasons:</p>
<ul>
<li>There is <strong>no TTC/PCa </strong>(e.g. polyp, benign hyperplasia).</li>
<li>The carcinoma is not caused by the BRAF gene mutation.</li>
<li>There are no mutated cells in the sample, even though a carcinoma is present (representativeness of the sample, cytology/urine low in cells).</li>
</ul>
<h2>BRAF mutations in feline urinary bladder carcinoma</h2>
<p>We examined biopsies of 25 cats with TCC (n=19), urinary bladder polyp (n=2) or cystitis (n=4) for the presence of BRAF mutation (HOHLOCH et al. 2019). There was no mutation detected in any case!<br />
Thus, BRAF mutation analysis is <strong>not suitable</strong> <strong>for</strong> the diagnosis of transitional cell carcinoma in<strong> cats</strong>.</p>

		</div>
	</div>
</div></div></div></div><div class="vc_row wpb_row vc_row-fluid vc_custom_1705308017634"><div class="wpb_column vc_column_container vc_col-sm-12"><div class="vc_column-inner"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element  vc_custom_1705308335744" >
		<div class="wpb_wrapper">
			<h5><strong>Literature</strong></h5>
<h6><span style="color: #808080;"><strong>AUPPERLE-LELLBACH H, GRASSINGER J, HOHLOCH C, KEHL A, PANTKE P (2018): Diagnostische Aussagekraft der BRAF-Mutation V595E in Urinproben, Ausstrichen und Bioptaten beim kaninen Harnblasenkarzinom. <em>Tieraerztliche Praxis Kleintier</em>. 46: 289–295.</strong></span></h6>
<h6><span style="color: #808080;"><strong>AUPPERLE-LELLBACH H, KEHL A, MERZ S, GRASSINGER J, HOHLOCH C, PANTKE P (2019): Die BRAF-Mutation V595E im Übergangszellkarzinom – Untersuchungen zur Rassedisposition bei Terriern. <em>Kleintiermedizin</em>. 1: 30–33.</strong></span></h6>
<h6><span style="color: #808080;"><strong>AUPPERLE-LELLBACH H, GRASSINGER J, ERHARD H, KEMPKER L, MERZ S, </strong></span><span style="color: #808080;"><strong>PANTKE P (2019): BRAF-mutation in carcinomas of various sites in the canine urinary tract. Abstract ECVIM 2019 in Milan, Italy</strong></span></h6>
<h6><span style="color: #808080;"><strong>BRYAN JN, KEELER MR, HENRY CJ, BRYAN ME, HAHN AW, CALDWELL CW (2007): A population study of neutering status as a risk factor for canine prostate cancer. <em>Prostate</em>. 67: 1174–1181.</strong></span></h6>
<h6><span style="color: #808080;"><strong>CORNELL KK, BOSTWICK DG, COOLEY DM, HALL G, HARVEY HJ, HENDRICK MJ, PAULI BU, RENDER JA, STOICA G, SWEET DC, WATERS DJ (2000): Clinical and pathologic aspects of spontaneous canine prostate carcinoma: A retrospective analysis of 76 cases. <em>Prostate</em>. 45: 173–183.</strong></span></h6>
<h6><span style="color: #808080;"><strong>FULKERSON CM, KNAPP DW (2015): Management of transitional cell carcinoma of the urinary bladder in dogs: a review. <em>Veterinary Journal</em>. 205: 217–225.</strong></span></h6>
<h6><span style="color: #808080;"><strong>GRASSINGER JM, MERZ S, AUPPERLE- LELLBACH H, ERHARD H, KLOPFLEISCH R (2019): Correlation of BRAF Variant V595E, Breed, Histological Grade and Cyclooxygenase-2 Expression in Canine Transitional Cell Carcinomas. <em>Veterinary sciences</em>. 6: doi: 10.3390/vetsci6010031.</strong></span></h6>
<h6><span style="color: #808080;"><strong>GRASSINGER JM, AUPPERLE-LELLBACH H, ERHARD H, MERZ S, KLOPFLEISCH R (2019): Nachweis der BRAF-Mutation bei kaninen Prostataerkrankungen. <em>Tieraerztliche </em><em>Praxis </em><em>Kleintier. </em><em>2019</em><em>; </em><em>47: 1–8</em></strong></span></h6>
<h6><span style="color: #808080;"><strong>GRIFFIN MA, CULP WTN, REBHUN RB (2018): Lower Urinary Tract Neoplasia. <em>Veteri</em><em>nary sciences</em>. 5: doi:10.3390/vetsci5040096</strong></span></h6>
<h6><span style="color: #808080;"><strong>HENRY CJ (2003): Management of transitional cell carcinoma. <em>The Veterinary clinics of North America. Small animal practice</em>. 33: 597–613.</strong></span></h6>
<h6><span style="color: #808080;"><strong>HOHLOCH C, KEHL A, AUPPERLE- LELLBACH H (2019): BRAF Variant V637E is not detectable in biopsies of feline transitional cell carcinoma. Abstract ESVCP-ECVP Congress, Arnheim, the Netherlands</strong></span></h6>
<h6><span style="color: #808080;"><strong>KNAPP DW, GLICKMAN NW, DENICOLA DB, BONNEY PL, LIN TL, GLICKMAN LT (2000): Naturally-occurring canine transitional cell carcinoma of the urinary bladder, a relevant model of human invasive bladder cancer. <em>Urologic Oncology: Seminars and Original Investigations</em>. 5: 47–59.</strong></span></h6>
<h6><span style="color: #808080;"><strong>MOCHIZUKI H, KENNEDY K, SHAPIRO SG, BREEN M (2015): BRAF Mutations in Canine Cancers. PloS one. 10: e0129534.</strong></span></h6>
<h6><span style="color: #808080;"><strong>PANTKE P (2018): Diagnostik und Therapie des Übergangszellkarzinoms des unteren Harntraktes beim Hund. <em>Kleintierpraxis</em>. 63: 76–92.</strong></span></h6>

		</div>
	</div>
</div></div></div></div><div class="vc_row wpb_row vc_row-fluid vc_custom_1705308401869 vc_column-gap-10 vc_row-o-equal-height vc_row-o-content-middle vc_row-flex"><div class="wpb_column vc_column_container vc_col-sm-2 vc_col-has-fill"><div class="vc_column-inner vc_custom_1721816988645"><div class="wpb_wrapper"><div class="vc_icon_element vc_icon_element-outer vc_custom_1721816995867 vc_do_icon vc_icon_element-align-center"><div class="vc_icon_element-inner vc_icon_element-color-custom vc_icon_element-size-xl vc_icon_element-style- vc_icon_element-background-color-grey" ><span class="vc_icon_element-icon fas fa-file-pdf" style="color:#e51e1e !important"></span><a class="vc_icon_element-link" href="https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_web.pdf"  title="BRAF mutation in canine transitional cell and prostate carcinoma" target="_blank"></a></div></div></div></div></div><div class="wpb_column vc_column_container vc_col-sm-10 vc_col-has-fill"><div class="vc_column-inner vc_custom_1721817014029"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element  vc_custom_1721817022925" >
		<div class="wpb_wrapper">
			<p><strong><a href="https://laboklin.com/wp-content/uploads/2019/10/LA_Oktober_2019_ENG_web.pdf" target="_blank" rel="noopener">BRAF mutation in canine transitional cell and prostate carcinoma</a></strong></p>

		</div>
	</div>
</div></div></div></div>
</div>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Assessment of renal function using laboratory parameters</title>
		<link>https://laboklin.com/en/assessment-of-renal-function-using-laboratory-parameters/</link>
		
		<dc:creator><![CDATA[Laboklin &#124; Bad Kissingen]]></dc:creator>
		<pubDate>Mon, 15 Jul 2019 11:00:36 +0000</pubDate>
				<category><![CDATA[LABOKLIN aktuell 2019]]></category>
		<guid isPermaLink="false">https://staging.laboklin.com/int/en/?p=1316673</guid>

					<description><![CDATA[In laboratory diagnostics, there are various parameters available for assessing the renal function that provide a good representation of the glomerular filtration rate (GFR).]]></description>
										<content:encoded><![CDATA[<div class="wpb-content-wrapper"><div class="vc_row wpb_row vc_row-fluid dt-default" style="margin-top: 0px;margin-bottom: 0px"><div class="wpb_column vc_column_container vc_col-sm-8"><div class="vc_column-inner"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			<p>In laboratory diagnostics, there are various parameters available for assessing the renal function that provide a good representation of the glomerular filtration rate <strong>(GFR).</strong></p>
<ul>
<li>
<p class="bodytext"><b><span lang="EN-US">Creatinine</span></b></p>
</li>
<li>
<p class="bodytext"><b></b><b><span lang="EN-US">Symmetric dimethyl-arginine (SDMA)</span></b></p>
</li>
<li>
<p class="bodytext"><b></b><b><span lang="EN-US">Urine-specific gravity (USG)</span></b></p>
</li>
<li>
<p class="bodytext"><b></b><b><span lang="EN-US">Protein/creatinine ration (U-P/C)</span></b></p>
</li>
</ul>
<table>
<tbody>
<tr style="color: #ffffff;" bgcolor="e51e1e">
<td width="73"></td>
<td style="text-align: center;" width="85">pre-renal</td>
<td style="text-align: center;" width="68">renal</td>
<td style="text-align: center;" width="85">postrenal</td>
</tr>
<tr>
<td width="73">creatinine</td>
<td style="text-align: center;" width="85">↑↓</td>
<td style="text-align: center;" width="68">↑</td>
<td style="text-align: center;" width="85">↑</td>
</tr>
<tr>
<td width="73">SDMA</td>
<td style="text-align: center;" colspan="3" width="238">↑</td>
</tr>
<tr>
<td width="73">USG</td>
<td style="text-align: center;" width="85">↑↓</td>
<td style="text-align: center;" width="68">↑↓</td>
<td width="85"></td>
</tr>
<tr>
<td width="73">U-P/C</td>
<td style="text-align: center;" width="85">↑</td>
<td style="text-align: center;" width="68">↑</td>
<td style="text-align: center;" width="85">↑</td>
</tr>
</tbody>
</table>

		</div>
	</div>
</div></div></div><div class="wpb_column vc_column_container vc_col-sm-4"><div class="vc_column-inner"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			
<a href='https://laboklin.com/en/assessment-of-renal-function-using-laboratory-parameters/sdma-english-2-2/'><img loading="lazy" decoding="async" width="1024" height="679" src="https://laboklin.com/wp-content/uploads/2019/09/SDMA-English-2-1024x679.jpg" class="attachment-large size-large" alt="" srcset="https://laboklin.com/wp-content/uploads/2019/09/SDMA-English-2-1024x679.jpg 1024w, https://laboklin.com/wp-content/uploads/2019/09/SDMA-English-2-300x199.jpg 300w, https://laboklin.com/wp-content/uploads/2019/09/SDMA-English-2-768x509.jpg 768w, https://laboklin.com/wp-content/uploads/2019/09/SDMA-English-2.jpg 1200w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></a>


		</div>
	</div>
</div></div></div></div><div class="vc_row wpb_row vc_row-fluid"><div class="wpb_column vc_column_container vc_col-sm-12"><div class="vc_column-inner vc_custom_1707307611181"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			<p>Measurement of <strong>GFR</strong> is the gold standard for determining the filtrative and resorptive capacity in chronic renal insufficiencies. In veterinary diagnostics, it had been determined by creatinine or inulin clearance for a long time. Because of the unavailability of creatinine and inulin, however, these tests can no longer be performed.</p>
<p><strong>Creatinine concentration</strong> in the serum represents the glomerular renal function with good specificity but at the same time with low sensitivity in the early stages of damage. Creatinine should be evaluated cautiously when assessing the renal function as it is prerenally influenced by several physiological factors (age, muscle mass, breed, feeding, hydration status). Postrenally, an obstruction of the urinary tract can lead to a stasis-induced increase. To assess the renal function, a primary, slight increase should be confirmed by repeated measurement. In general, a simultaneous urinalysis is always recommended. Preanalytically, haemolysis, lipidaemia or icterus impair the measurement of creatinine concentration.</p>
<p>Urea is a reliable parameter for assessing the glomerular renal function. However, serum concentration is subject to many pre- and postrenal influences. Urea is synthesised in the liver during amino acid degradation. It is excreted glomerularly and proportionately reabsorbed tubularly. Prerenally, urea concentration in the serum may increase due to food intake, catabolic metabolism and endocrinopathies such as Cushing’s disease or diabetes mellitus, and in case of hepatopathies with impaired function, it may decrease. Postrenally, urinary flow disorders lead to increased levels in the serum.</p>
<p>Another serum parameter used to assess renal function is <strong>SDMA</strong>. It is a non-proteinogenic amino acid that is produced during protein degradation. More than 90% of SDMA is glomerularly filtered and renally eliminated. In the early stages of glomerular nephropathy, SDMA is currently the most sensitive diagnostic parameter, as it already increases if GFR is reduced by 30% (creatinine only increases from 70% onwards). Thus, the isolated increase in SDMA concentration is a first indication of the onset of renal insufficiency. In patients with chronic renal insufficiency, who are often cachectic, renal function can further be monitored independent of muscle mass by measuring the SDMA concentration.</p>
<p>Compared to creatinine, urine specific gravity <strong>(USG)</strong> is a sensitive parameter as well and is the first to increase in case of renal insufficiency. Affected kidneys lose the ability to concentrate urine. The patient’s hydration status must be taken into account. Decreased USG alone is not specific for impaired renal function. Again, repeated measurement of several urine samples throughout the day is important for evaluation. Only a persistently low USG can be considered a pathological finding.</p>
<ol>
<li><strong>Hypersthenuria (dog: &gt; 1.030, cat: &gt; 1.035):</strong> No indication of impaired renal function. Possibly other underlying disease.</li>
<li><strong>Normosthenuria (dog: 1.013 – 1.029, cat: 1.013 – 1.034):</strong> Normal renal function. Concurrent persistent azotaemia or proteinuria may indicate partial loss of nephrons.</li>
<li><strong>Isosthenuria (1.008 – 1.012):</strong> The USG of the urine corresponds to that of the ultrafiltrate. In case of concurrent azotaemia, this may indicate renal insufficiency in an advanced stage or nonrenal influences on the USG: hydration status, medication, hormonal influences (e.g. ADH), electrolyte changes, hepatic dysfunction, bacterial infections (e.g. E. coli), way of feeding (e.g. protein content, salt content).</li>
<li><strong>Hyposthenuria (&lt; 1.008):</strong> independent of renal function (e.g. diabetes insipidus). The evaluation of the <strong>protein excretion</strong> in the urine should always be performed in conjunction with the evaluation of the USG and a urinary status/sediment (Figure).</li>
</ol>
<p>For quantifying proteinuria, the protein/creatinine ratio UP/C is determined in urine. After IRIS staging, the UP/C reflects the extent of renal protein loss.</p>
<p>At times, low-grade proteinuria is physiological, whereas pathological proteinuria persists (medium to highgrade). Causes for extrarenal, high-grade proteinuria are listed in the table below.</p>
<table>
<tbody>
<tr style="color: #ffffff;" bgcolor="e51e1e">
<td width="114"><strong>DOG</strong></td>
<td width="4"></td>
<td colspan="3" width="225"><strong>CAT</strong></td>
</tr>
<tr>
<td width="114">U-P/C &lt; 0.2</td>
<td rowspan="3" width="4"></td>
<td width="122">U-P/C &lt; 0.2</td>
<td rowspan="3" width="4"></td>
<td width="103">no proteinuria</td>
</tr>
<tr>
<td width="114">U-P/C 0.2 – 0.5</td>
<td width="122">U-P/C 0.2 – 0.4</td>
<td width="103">borderline proteinuria</td>
</tr>
<tr>
<td width="114">U-P/C &gt; 0.5</td>
<td width="122">U-P/C &gt; 0.4</td>
<td width="103">proteinuria</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
<p>Causes for extra-renal, high-grade proteinuria</p>
<table>
<tbody valign="top">
<tr style="color: #ffffff;" bgcolor="e51e1e">
<td width="166"><strong>Infectious diseases</strong></td>
<td width="166"><strong>Immune-mediated diseases</strong></td>
<td width="166"><strong>Neoplasia</strong></td>
<td width="187"><strong>Glomerulopathies</strong> <strong>(GP)</strong></td>
</tr>
<tr>
<td width="166">•  leishmaniosis</p>
<p>•  ehrlichiosis<br />
•  babesiosis<br />
•  dirofilariosis<br />
•  borreliosis<br />
•  FeLV, FIV, FIP</td>
<td width="166">• systemic lupus</p>
<p>• IgA nephropathy</td>
<td width="166">• monoclonal gammopathy</p>
<p>• plasmocytoma</td>
<td width="187">• amyloidosis</p>
<p>• membranous GP</p>
<p>• membrano-proliferative GP</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
<p>However, medium or low-grade proteinuria does not exclude nephropathy. It is therefore important to localise proteinuria to distinguish between physiological, temporary proteinuria (exertion, exposure to heat or cold, stress) and pathological proteinuria. Pathologically, glomerular as well as tubular or interstitial proteinuria can occur.</p>
<p>This can be diagnostically differentiated by urinary electrophoresis.</p>
<p>In male dogs, retrograde ejaculation can also cause proteinuria. There are not always sperms in the urine samples, which makes diagnosis difficult.</p>
<p>Diseases leading to a restriction of tubular renal function include cystinuria and Fanconi syndrome.</p>
<p>Both diseases are characterised by an increased excretion of amino acids in the urine. Both diseases may or may not be associated with an increase in UP/C.</p>
<p>Cystinuria is a genetic amino acid transport disorder in dogs and rarely in cats. The mutation is known in the breeds Australian Cattle Dog, Continental Bulldog, English Bulldog, French Bulldog, Labrador Retriever, Landseer, Mastiff, Newfoundland, Olde English Bulldogge and Miniature Pinscher. The patients lack a transmembrane transport protein in the epithelial cells of the small intestine and in the proximal tubular cells that reabsorbs cystine, ornithine, lysine and arginine. The excretion of cystine via the kidney is increased to the rate of 20 to 30 times the norm, while the concentration in the blood remains unchanged. Cystine is poorly solublein normal urinary pH. If the concentration is ≥ 300 mg/l or more, crystals precipitate in the urine. Often, calculi are formed. Diagnosis is made by genetic testing or, in animals in which the mutation is not known, by determining the concentration of amino acids in the urine – the COLA test.</p>
<p>In clinically affected animals, cystine crystals are found in the sediment.</p>
<p>Fanconi syndrome is a genetic disease that occurs in Basenjis. Idiopathically, it has been identified in Norwegian Elkhound, Labrador Retriever, Sheltie and Miniature Schnauzer. Acquired Fanconi syndrome is caused by the toxic effects of certain medication, heavy metal poisoning or feeding of disproportionately large amounts of dried meat. Dried meat causes a deficit in tubular reabsorption of glucose, amino acids and bicarbonate. The result is renal tubular acidosis. The clinical picture often corresponds to that of patients with glomerular renal insufficiency with apathy, inappetence, PU/PD, weight loss, dehydration, weakness, vomitus.</p>
<p>In the blood test, neutrophilia with a mild left shift, changes in the clinical chemical parameters and in the urinary status/sediment are noticeable (see Table). The definite diagnosis is made by quantitative determination of the amino acids threonine, glutamine, proline, glycine and alanine in the urine with simultaneous semiquantitative measurement of glucose excretion.</p>
<table>
<tbody valign="top">
<tr style="color: #ffffff;" bgcolor="e51e1e">
<td width="114"></td>
<td width="173"><strong>Cystinuria</strong></td>
<td width="173"><strong>Fanconi syndrome</strong></td>
<td width="173"><strong>Diabetes</strong></td>
</tr>
<tr>
<td width="114"><strong>Urine</strong></td>
<td width="173">U-P/C↑≈, cystine crystals, COLA↑</td>
<td width="173">U-P/C↑≈, COLA↑≈, glucose↑, amino acids</td>
<td width="173">U-P/C↑≈, glucose↑,</td>
</tr>
<tr>
<td width="114"><strong>Serum</strong></td>
<td width="173">normal</td>
<td width="173">Cl ↑, glucose ≈↓, K↓, PO4↓, Na↓, fructosamines↓, urea↑, creatinine↑, aldosterone↑, ALT↑</td>
<td width="173">glucose↑, fructosamines↑, Na↑↓, K↓↑, PO4↓</td>
</tr>
</tbody>
</table>

		</div>
	</div>
</div></div></div></div><div class="vc_row wpb_row vc_row-fluid vc_custom_1705312707124 vc_column-gap-10 vc_row-o-equal-height vc_row-o-content-middle vc_row-flex"><div class="wpb_column vc_column_container vc_col-sm-2 vc_col-has-fill"><div class="vc_column-inner vc_custom_1721817107762"><div class="wpb_wrapper"><div class="vc_icon_element vc_icon_element-outer vc_custom_1721817115457 vc_do_icon vc_icon_element-align-center"><div class="vc_icon_element-inner vc_icon_element-color-custom vc_icon_element-size-xl vc_icon_element-style- vc_icon_element-background-color-grey" ><span class="vc_icon_element-icon fas fa-file-pdf" style="color:#e51e1e !important"></span><a class="vc_icon_element-link" href="https://laboklin.com/wp-content/uploads/2023/02/assessment-of-renal-function-using-laboratory-parameters-2.pdf"  title="" target="_blank"></a></div></div></div></div></div><div class="wpb_column vc_column_container vc_col-sm-10 vc_col-has-fill"><div class="vc_column-inner vc_custom_1721817126091"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element  vc_custom_1721817134101" >
		<div class="wpb_wrapper">
			<p><a href="https://laboklin.com/wp-content/uploads/2023/02/assessment-of-renal-function-using-laboratory-parameters-2.pdf" target="_blank" rel="noopener"><strong>Assessment of renal function using laboratoy parameters</strong></a></p>

		</div>
	</div>
</div></div></div></div>
</div>]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Infectious conjunctivitis and keratitis in dogs and cats: pathogen distribution, level of resistance, treatment options</title>
		<link>https://laboklin.com/en/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options/</link>
		
		<dc:creator><![CDATA[Laboklin &#124; Bad Kissingen]]></dc:creator>
		<pubDate>Mon, 07 Jan 2019 12:00:43 +0000</pubDate>
				<category><![CDATA[LABOKLIN aktuell 2019]]></category>
		<guid isPermaLink="false">https://staging.laboklin.com/int/en/?p=1316682</guid>

					<description><![CDATA[The new version of the German Veterinary Pharmacy Act (TÄHAV), which has been in force since 1st March 2018, has raised some questions regarding the treatment of (kerato) conjunctivitis. ]]></description>
										<content:encoded><![CDATA[<div class="wpb-content-wrapper"><div class="vc_row wpb_row vc_row-fluid dt-default" style="margin-top: 0px;margin-bottom: 0px"><div class="wpb_column vc_column_container vc_col-sm-8"><div class="vc_column-inner"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			<p>The new version of the German Veterinary Pharmacy Act (TÄHAV), which has been in force since 1st March 2018, has raised some questions regarding the treatment of keratoconjunctivitis. Since the TÄHAV came into effect, the main problem for practitioners lies in the fact that, so far, keratoconjunctivitis in dogs and cats has frequently been treated with antibiotic agents that have no approval for use in these animal species in Germany or even contain reserve antibiotics belonging to the  gyrase inhibitor group. We have therefore compared the infectious causes of these diseases with current diagnostic data and show the level of resistance of the pathogens involved to selected agents.</p>
<h2>(Kerato)conjunctivitis in cats</h2>
<p>Primary infections in cats are mainly caused by feline herpesvirus-1 (FHV-1), closely followed by chlamydia. FHV-1 multiplies in the epithelial cells – including those of the cornea – which is why damage to the cornea (keratoconjunctivitis) with possible subsequent ulceration can occur. These ulcers are almost always secondarily infected with bacteria. Ulcers are a complication that is less frequently seen in chlamydia infections. <em>Chlamydia felis</em> is highly contagious and is shed in eye and nose secretions. <em>Mycoplasma felis</em> is another primary but much rarer cause of conjunctivitis in cats. PCR is the usual detection method for these three primary pathogens. We determine all three pathogens in one eye profile. The material to be submitted is an eye swab rich in cells obtained with a dry swab and sent <strong>without</strong> <strong>transport medium!<br />
</strong>Fig. 1 shows the detection frequency of the individual pathogens from the second half of 2017 (total number of samples: 481). PCR detection was positive in 46% of cases, with 39% of all samples tested showing a mono-infection with one of the pathogens and 7% of the samples showing a multiple infection.</p>
<p>Multiple infections most often occurred in combination with mycoplasma, a result consistent with studies in other countries. According to one study, co-infections are associated with more severe clinical signs than single infections. Although FHV-1 is considered to be the most common primary pathogen of the clinical picture mentioned, it cannot be detected in a prolonged infection because the virus is only shed for a maximum of 10 days after infection. Thus, chlamydia have the highest detection frequency in PCR detection, as PCR is often only performed in case of a chronic illness or after the first treatment failed. However, like all herpes viruses, FHV-1 cannot be eliminated, but retreats to different body parts and remains latent there. Triggered by other diseases, stress or corticosteroid treatment, virus shedding can occur again at any time and also lead to recurring clinical signs.</p>
<p>Mild forms of FHV-1-related keratoconjunctivitis are often self-limiting. In severe clinical cases or in case of persistent relapse, however, oral or topical antiviral medication should be used. For chlamydia and mycoplasma, there are no methods established for routine resistance testing. In therapy, antibiotics that have a known effect against these pathogens are used. This also conforms to the TÄHAV. Tetracyclines, chloramphenicol or gyrase inhibitors – used three to four times a day as eye ointment or drops – have a good effect against these pathogens. In case of chlamydia, topical therapy is sometimes not sufficient to eliminate the pathogens in cats, especially if the excretion also occurs via other mucous membranes, e.g. of the genital tract. In these cases, additional oral treatment with doxycycline for 30 days is indicated, especially in multi-cat households. Here, it is recommended to treat all cats of the household with doxycycline. Because of the strong side effects of doxycycline alone, such an approach should be backed up by PCR in any case.</p>
<p>Frequently, the original primary infection is secondarily colonised by facultative pathogenic, aerobic bacteria. Particularly FHV-1-related ulcers are often secondarily infected with bacteria. 866 swab samples of eye swabs from 2017 were bacteriologically evaluated. Fig. 2 shows the pathogen distribution of these samples. Staphylococci take up by far the largest part of detected pathogens, but only 4% of these ocular staphylococci show multiresistance.</p>
<p>In mild clinical cases, empirical topical treatment is often sufficient, since local application achieves a high concentration of active ingredients directly at the site of infection. Cytology can provide information on whether there are indications of inflammation with bacterial involvement. Sampling should be done before the application of cleaning substances or fluorescein. Swabs for bacteriological examination with resistance test must be sent <strong>with transport medium</strong>! According to a new study conducted by the University of Berlin together with Laboklin, moistening the swab with sterile physiological saline solution improves the detection rate of gram-positive pathogens. The swab should not be placed directly in the pus, as the pathogens contained therein are in a phagocytised form and may therefore not be cultivable.</p>
<p>Although Diff-Quick staining prepared in the practice from a second swab for cytology does not give any indication of the presence of gram-positive or gram-negative pathogens, it does, however, indicate whether bacilli or cocci are present in the preparation. When taking a closer look at the distribution of pathogens, it becomes clear that bacilli always need to be classified as gram-negative and cocci, with the exception of <em>Acinetobacter spp</em>., always as gram-positive. However, <em>Acinetobacter spp.</em> do not play a pathogenic role in conjunctivitis. That is why we have each combined bacilli and cocci in the presentation of the current resistance behaviour, since the cytological results can thus be transferred directly to the empirical selection of an antibiotic (see Figs. 3 and 4).</p>
<p>For cats, there are topical preparations approved in Germany and available on the market for the active substances tetracycline, neomycin and gentamicin (source: Vetidata, December 2018).</p>

		</div>
	</div>
</div></div></div><div class="wpb_column vc_column_container vc_col-sm-4"><div class="vc_column-inner"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			
<a href='https://laboklin.com/en/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options/la-2019-01-auge_en-end_seite_1_bild_0001/'><img loading="lazy" decoding="async" width="529" height="327" src="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_1_Bild_0001.jpg" class="attachment-large size-large" alt="Laboklin: PCR pathogen detection eye profile cats" srcset="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_1_Bild_0001.jpg 529w, https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_1_Bild_0001-300x185.jpg 300w" sizes="auto, (max-width: 529px) 100vw, 529px" /></a>
<a href='https://laboklin.com/en/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options/la-2019-01-auge_en-end_seite_2_bild_0001/'><img loading="lazy" decoding="async" width="514" height="321" src="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_2_Bild_0001.jpg" class="attachment-large size-large" alt="Laboklin: Pathogen distribution eyes cats (n = 622)" srcset="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_2_Bild_0001.jpg 514w, https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_2_Bild_0001-300x187.jpg 300w" sizes="auto, (max-width: 514px) 100vw, 514px" /></a>
<a href='https://laboklin.com/en/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options/la-2019-01-auge_en-end_seite_2_bild_0002/'><img loading="lazy" decoding="async" width="452" height="275" src="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_2_Bild_0002.jpg" class="attachment-large size-large" alt="Laboklin: Resistance pattern cocci cats (n = 479)" srcset="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_2_Bild_0002.jpg 452w, https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_2_Bild_0002-300x183.jpg 300w" sizes="auto, (max-width: 452px) 100vw, 452px" /></a>
<a href='https://laboklin.com/en/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options/la-2019-01-auge_en-end_seite_2_bild_0003/'><img loading="lazy" decoding="async" width="441" height="279" src="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_2_Bild_0003.jpg" class="attachment-large size-large" alt="Laboklin: Resistance pattern bacilli cats (n = 143)" srcset="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_2_Bild_0003.jpg 441w, https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_2_Bild_0003-300x190.jpg 300w" sizes="auto, (max-width: 441px) 100vw, 441px" /></a>
<a href='https://laboklin.com/en/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options/la-2019-01-auge_en-end_seite_3_bild_0001/'><img loading="lazy" decoding="async" width="518" height="394" src="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_3_Bild_0001.jpg" class="attachment-large size-large" alt="Laboklin: Pathogen distribution eyes dogs (n = 1309)" srcset="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_3_Bild_0001.jpg 518w, https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_3_Bild_0001-300x228.jpg 300w" sizes="auto, (max-width: 518px) 100vw, 518px" /></a>
<a href='https://laboklin.com/en/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options/la-2019-01-auge_en-end_seite_4_bild_0001/'><img loading="lazy" decoding="async" width="449" height="266" src="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0001.jpg" class="attachment-large size-large" alt="Laboklin: Resistance pattern cocci dogs (n = 903)" srcset="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0001.jpg 449w, https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0001-300x178.jpg 300w" sizes="auto, (max-width: 449px) 100vw, 449px" /></a>
<a href='https://laboklin.com/en/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options/la-2019-01-auge_en-end_seite_4_bild_0002/'><img loading="lazy" decoding="async" width="441" height="269" src="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0002.jpg" class="attachment-large size-large" alt="Laboklin: Resistance pattern bacilli dogs (n = 406)" srcset="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0002.jpg 441w, https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0002-300x183.jpg 300w" sizes="auto, (max-width: 441px) 100vw, 441px" /></a>
<a href='https://laboklin.com/en/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options/la-2019-01-auge_en-end_seite_4_bild_0003/'><img loading="lazy" decoding="async" width="438" height="271" src="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0003.jpg" class="attachment-large size-large" alt="Laboklin: Resistance pattern Ps. aeruginosa dogs (n = 57)" srcset="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0003.jpg 438w, https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0003-300x186.jpg 300w" sizes="auto, (max-width: 438px) 100vw, 438px" /></a>
<a href='https://laboklin.com/en/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options/la-2019-01-auge_en-end_seite_4_bild_0004/'><img loading="lazy" decoding="async" width="441" height="269" src="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0004.jpg" class="attachment-large size-large" alt="Laboklin: Resistance pattern staphylococci dogs (n = 620)" srcset="https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0004.jpg 441w, https://laboklin.com/wp-content/uploads/2019/01/LA-2019-01-Auge_EN-End_Seite_4_Bild_0004-300x183.jpg 300w" sizes="auto, (max-width: 441px) 100vw, 441px" /></a>


		</div>
	</div>
</div></div></div></div><div class="vc_row wpb_row vc_row-fluid dt-default" style="margin-top: 0px;margin-bottom: 0px"><div class="wpb_column vc_column_container vc_col-sm-12"><div class="vc_column-inner vc_custom_1705315121987"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element " >
		<div class="wpb_wrapper">
			<p>According to the new TÄHAV, there is no obligation to perform an antibiogram for these antibiotics. Chloramphenicol is available in a formulation approved for use on animals in other EU countries. Floxal® eye ointment with the active ingredient ofloxacin is a human medicine preparation that, so far, has been very popular in the small animal practice. As ofloxacin is not tested in our antibiogram, the results for enrofloxacin have been included in the evaluation instead. Looking at the results, it can be seen that in cocci tetracycline is even better than gyrase inhibitors, while the level of resistance in bacilli is similar. Both antibiotics also reach chlamydia and mycoplasma well. Thus, an approved preparation is available, since for Floxal® ointment, the new TÄHAV prohibits any extra-label use. If an exception to this prohibition can be justified, it is obligatory to perform an antibiogram in any case (use of a gyrase inhibitor and extra-label use according to level 3 §56a AMG (German Drug Law)). Another advantage of tetracycline is that it has an epithelising effect on corneal ulcers by inhibiting the matrix metalloproteinases produced by the corneal epithelium and promoting collagen lysis. Chloramphenicol ointment would also have a good effect, at least against cocci, and is also effective against chlamydia and mycoplasma, but according to the new TÄHAV it is subject to the obligation to perform an antibiogram, as it is veterinary medicine imported from abroad (level 3 of the Cascade Rule §56a AMG). The approved eye ointment containing neomycin basically has the disadvantage that it also contains a corticosteroid. As (kerato)conjunctivitis in cats is usually infectious, the immunosuppression triggered by the steroid may have a massive negative effect on the infection. Recently, eye drops containing gentamicin have been approved for cats in Germany. They do not contain steroids. In bacilli, the level of resistance is better than that of tetracycline.</p>
<h2>(Kerato)conjunctivitis in dogs</h2>
<p>In contrast to cats, viruses, chlamydia or mycoplasma play only a minor role as primary pathogens of keratoconjunctivitis in dogs. A look at the results of the eye profile from the second half of 2017 (PCR detection for canine herpesvirus, chlamydia and mycoplasma) shows: only 6.4% of 108 samples examined were positive. Multiple infections did not occur and mycoplasma was most frequently detected with 4.6%.</p>
<p>In dogs, conjunctivitis is often associated with atopy. There are neither clinical nor cytological signs of a real infection (no purulent discharge, no phagocytised bacteria). In addition to the increased presence of keratinised epithelial cells, lymphocytes and eosinophils, there are extracellular bacteria and malassezia that are also found in cytology. These pathogens occur even more often than in healthy dogs. However, antibiotic treatment is not indicated here. For some time now, there have been eye drops containing a corticosteroid that are approved for this field of application in dogs.</p>
<p>In dogs, infections of the conjunctiva are mostly secondary, e.g. in connection with keratoconjunctivitis sicca. The pathogen distribution is shown in Fig. 5.</p>
<p>For this purpose, 1396 swab samples of eye swabs from 2017 were evaluated. Staphylococci take up by far the largest part of detected pathogens; only 1% of these ocular staphylococci show multiresistance.</p>
<p>The resistance pattern in dogs is shown in the same way as it was done for cats (see explanation there, Figs. 6 and 7). In addition to the approved preparations for cats, there is an approved eye ointment with fusidic acid for dogs.</p>
<p>Infected corneal defects play a special role in dogs. They can quickly become deep ulcers and it is generally necessary to act quickly to protect the eye from massive damage. The pathogens involved are usually staphylococci or <em>Pseudomonas aeruginosa</em>. Treatment should be based on a bacteriological examination with resistance test, but as a start, gentamicin or ofloxacin can be used topically until the result is received. According to the new TÄHAV, however, a good justification is needed for any extra-label use of ofloxacin, and there is an obligation to perform an antibiogram (see the chapter on cats).</p>
<p>With the results shown in Figs. 8 and 9, gentamicin would be preferable to gyrase inhibitors.</p>
<p>Additionally, according to a recent study, prolonged administration of ofloxacin leads to an altered conjunctival flora with an increase in resistance to this antibiotic.</p>
<p>Another study showed that ofloxacin was not superior to aminoglycoside in the long-term healing of the disease. Thus, the gyrase inhibitor could also be avoided in this disease, as it should only be used selectively and can promote the rapid spread of resistances. Topically applied corticosteroids should be avoided when treating corneal ulcers.</p>
<h2>Conclusion</h2>
<p>In cats, PCR should be used regularly and at an early stage to clarify primary infectious agents, as FHV-1 infections and chlamydia may require measures beyond topical antibiotic therapy. Primary pathogens often cause a secondary infection with facultative pathogenic agents. Multi-resistant ocular pathogens are rare. There are preparations approved for dogs and cats for which there is no obligation to perform an antibiogram according to the new TÄHAV and which show excellent efficacy in various clinical pictures. According to antibiotic guidelines, a bacteriological examination with resistance test should be carried out in case of relapses and when changing antibiotics because of treatment failure. This is understood as a responsible approach to antibiotics. There is almost no need to use gyrase inhibitors; here, an antibiogram according to TÄHAV would be required in any case.</p>

		</div>
	</div>
</div></div></div></div><div class="vc_row wpb_row vc_row-fluid vc_custom_1705314089196 vc_column-gap-10 vc_row-o-equal-height vc_row-o-content-middle vc_row-flex"><div class="wpb_column vc_column_container vc_col-sm-2 vc_col-has-fill"><div class="vc_column-inner vc_custom_1721817378213"><div class="wpb_wrapper"><div class="vc_icon_element vc_icon_element-outer vc_custom_1721817385729 vc_do_icon vc_icon_element-align-center"><div class="vc_icon_element-inner vc_icon_element-color-custom vc_icon_element-size-xl vc_icon_element-style- vc_icon_element-background-color-grey" ><span class="vc_icon_element-icon fas fa-file-pdf" style="color:#e51e1e !important"></span><a class="vc_icon_element-link" href="https://laboklin.com/wp-content/uploads/2023/02/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options-2.pdf"  title="" target="_blank"></a></div></div></div></div></div><div class="wpb_column vc_column_container vc_col-sm-10 vc_col-has-fill"><div class="vc_column-inner vc_custom_1721817397879"><div class="wpb_wrapper">
	<div class="wpb_text_column wpb_content_element  vc_custom_1721817407388" >
		<div class="wpb_wrapper">
			<p><a href="https://laboklin.com/wp-content/uploads/2023/02/infectious-conjunctivitis-and-keratitis-in-dogs-and-cats-pathogen-distribution-level-of-resistance-treatment-options-2.pdf" target="_blank" rel="noopener"><strong>Infectious conjunctivitis and keratitis in dogs and cats: pathogen distribution, level of resistance, treatment options</strong></a></p>

		</div>
	</div>
</div></div></div></div>
</div>]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
